---
category: listing
circular_id: bed780e07498d567
date: '2025-12-31'
description: 16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on
  BSE effective January 1, 2026, issued through preferential allotment via warrant
  conversion.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={D243424B-B1C3-4092-807E-40C0A57AE015}&noticeno=20251231-15&dt=12/31/2025&icount=15&totcount=15&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of new securities for a single company through preferential
  allotment. Limited market-wide impact.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251231-15&attachedId=
processing:
  attempts: 1
  content_hash: 57f8931b1115e2d5
  processed_at: '2025-12-31T09:28:26.170115'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-31T09:10:42+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={D243424B-B1C3-4092-807E-40C0A57AE015}&noticeno=20251231-15&dt=12/31/2025&icount=15&totcount=15&flag=0
severity: low
source: bse
stocks:
- NOVELIX
tags:
- listing
- preferential-allotment
- warrant-conversion
- equity-shares
- lock-in
- novelix-pharmaceuticals
title: Listing of New Securities of NOVELIX PHARMACEUTICALS LIMITED
---

## Summary

BSE has listed 16,61,000 new equity shares of NOVELIX PHARMACEUTICALS LIMITED (Scrip Code: 536565) effective from January 1, 2026. These shares were issued at Rs. 20/- per share (face value Rs. 10/- plus premium of Rs. 10/-) to Promoter and Non-Promoter on a preferential basis pursuant to conversion of warrants. The shares rank pari-passu with existing equity shares.

## Key Points

- Total new shares listed: 16,61,000 equity shares of Rs. 10/- each
- Issue price: Rs. 20/- per share (including Rs. 10/- premium)
- Allotment date: October 23, 2025
- Trading commencement: January 1, 2026
- Distinctive numbers: 14480001 to 16141000
- ISIN: INE314I01036
- Shares rank pari-passu with existing equity shares
- Issued on preferential basis through warrant conversion

## Regulatory Changes

No regulatory changes introduced. This is a standard listing notification.

## Compliance Requirements

Trading members must note the listing of these new securities for trading purposes effective January 1, 2026.

## Important Dates

- **Allotment Date**: October 23, 2025
- **Trading Start Date**: January 1, 2026
- **Lock-in Expiry (11,25,000 shares)**: July 31, 2027
- **Lock-in Expiry (5,36,000 shares)**: July 31, 2026

## Lock-in Details

- 11,25,000 shares (Dist. Nos. 14480001 to 15605000) locked in until July 31, 2027
- 5,36,000 shares (Dist. Nos. 15605001 to 16141000) locked in until July 31, 2026

## Impact Assessment

Limited impact on broader market. This is a company-specific corporate action involving preferential allotment to promoters and non-promoters. The lock-in periods indicate regulatory compliance for preferential issues. The new shares represent capital raised through warrant conversion, potentially strengthening the company's equity base.